Context Therapeutics financial statements

콘텍스트 테라퓨틱스NASDAQ:CNTX · Nasdaq · Healthcare · sector #17
$0.3218-4.37%
2026-10-06 close

Context Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$30M.

Reported results

Context Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy